Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash & Equivalents (2016 - 2025)

Organogenesis Holdings has reported Cash & Equivalents over the past 9 years, most recently at $93.7 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $93.7 million for Q4 2025, down 30.9% from a year ago — trailing twelve months through Dec 2025 was $93.7 million (down 30.9% YoY), and the annual figure for FY2025 was $93.7 million, down 30.9%.
  • Cash & Equivalents for Q4 2025 was $93.7 million at Organogenesis Holdings, up from $63.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ORGO hit a ceiling of $135.6 million in Q4 2024 and a floor of $63.7 million in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $98.2 million (2023), compared with a mean of $98.4 million.
  • Biggest five-year swings in Cash & Equivalents: surged 35.0% in 2021 and later plummeted 32.43% in 2025.
  • Organogenesis Holdings' Cash & Equivalents stood at $113.9 million in 2021, then fell by 10.05% to $102.5 million in 2022, then grew by 1.33% to $103.8 million in 2023, then skyrocketed by 30.56% to $135.6 million in 2024, then plummeted by 30.9% to $93.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $93.7 million (Q4 2025), $63.7 million (Q3 2025), and $73.1 million (Q2 2025) per Business Quant data.